Here is a thorough overview of Asthalin (Salbutamol/Albuterol):
Asthalin (Salbutamol / Albuterol)
Brand names: Asthalin, Ventolin, ProAir, Proventil, AccuNeb, Airomir
Drug class: Short-Acting Beta-2 Adrenergic Agonist (SABA)
Generic names: Salbutamol (international INN) / Albuterol (US name)
Mechanism of Action
Asthalin acts selectively on beta-2 adrenergic receptors in bronchial smooth muscle. Stimulation activates adenylyl cyclase, raises intracellular cAMP, and causes smooth muscle relaxation - resulting in bronchodilation. It also inhibits mast cell mediator release and reduces microvascular leakage, though it has no significant effect on chronic airway inflammation (unlike corticosteroids).
- Onset of action: 3-5 minutes after inhalation
- Peak effect: 30-120 minutes
- Duration: 2-5 hours (up to 4-6 hours for COPD use)
(Goodman & Gilman's Pharmacological Basis of Therapeutics; Goldman-Cecil Medicine)
Indications / Uses
| Indication | Role |
|---|
| Acute asthma attack / exacerbation | First-line rescue bronchodilator |
| COPD (chronic bronchitis, emphysema) | Relieves acute symptoms; reduces dyspnea |
| Exercise-induced bronchospasm | Taken 15-30 min before exercise to prevent bronchospasm |
| Allergen-induced bronchospasm | Protects against cat/dog fur, pollen, dust triggers |
| Smoke inhalation with bronchospasm | Nebulized salbutamol to relieve bronchospasm |
| Bronchospasm prevention (perioperative) | Used in high-risk patients with reactive airways |
SABAs are the mainstay of acute asthma therapy and are effective for relieving acute bronchospasm. However, they should be used as needed (not on a regular scheduled basis) for mild asthma - increased use is a signal that better anti-inflammatory control is needed.
Available Formulations
| Form | Dose | Notes |
|---|
| MDI (Metered-Dose Inhaler) | 90-200 mcg/puff | Most common; Asthalin HFA 100 mcg/puff |
| DPI (Dry Powder Inhaler) | 100 or 200 mcg/inhalation | Patient-generated airflow required |
| Nebulizer solution | 0.63-5 mg/mL | Mixed with normal saline for nebulization |
| Oral tablets/syrup | Occasionally used | Higher systemic side effects; slow-release for nocturnal asthma |
| IV / IM | Used in severe/hospital cases | Less preferred than nebulized route |
Dosage
Adults (MDI - Rescue):
- 1-2 puffs (100-200 mcg) every 4-6 hours as needed
- Max: 10-12 puffs in 24 hours; more than 6 puffs/day warrants medical review
Acute severe asthma (ED/hospital):
- Continuous or intermittent nebulization; 2.5-5 mg via nebulizer, can be repeated every 20 minutes x 3 doses
Nebulizer (smoke inhalation/bronchospasm):
- 0.5 mL of 5 mg/mL solution diluted with 2 mL normal saline
Pediatric (MDI via spacer):
- 1-3 years: 4 puffs/dose
- 4-6 years: 6 puffs/dose
Exercise-induced prevention: 2 puffs 15-30 minutes before exercise
(Tintinalli's Emergency Medicine; Goldman-Cecil Medicine)
Side Effects
Common:
- Tremor (skeletal muscle)
- Tachycardia / palpitations
- Headache
- Nervousness / anxiety
- Hypokalemia (with high doses - beta-2 stimulates K+ uptake into cells)
Less common:
- Muscle cramps
- Dizziness
- Throat irritation
Serious (rare):
- Paradoxical bronchospasm
- Chest pain / arrhythmias
- Severe allergic reaction (hypersensitivity)
(Goldman-Cecil Medicine; Tintinalli's Emergency Medicine)
Contraindications & Precautions
- Allergy to salbutamol or any excipient - do not use
- Cardiovascular disease (use with caution - can cause tachycardia)
- Hyperthyroidism - may exacerbate symptoms
- Diabetes mellitus - can raise blood glucose and lower potassium
- Pregnancy - use only if prescribed by a doctor; IV salbutamol is used in obstetrics for tocolysis but inhaled doses carry low fetal risk
- Prior serious adverse reaction to albuterol/salbutamol - contraindicated per clinical pathways
Important Clinical Notes
- Not for maintenance use alone - SABAs are rescue medications. Frequent use (>2 days/week) indicates inadequate asthma control and the need for inhaled corticosteroids (ICS).
- Combine with ipratropium in moderate-to-severe acute asthma exacerbations for added bronchodilation without extra side effects.
- Levalbuterol (R-enantiomer of salbutamol) is not more effective or safer and is considerably more expensive.
- Oral route has more systemic side effects than inhalation - inhalation is always preferred when possible.
- COPD: Produces modest FEV1 improvement and symptom relief but does not modify disease progression; long-acting agents (salmeterol, formoterol) are preferred for maintenance.
Drug Interactions
- Non-selective beta-blockers (e.g., propranolol): Antagonize bronchodilator effect; can precipitate bronchospasm
- MAO inhibitors / tricyclic antidepressants: Potentiate cardiovascular effects
- Diuretics: Additive hypokalemia risk
- Digoxin: Hypokalemia from salbutamol can increase digoxin toxicity
Key takeaway: Asthalin (salbutamol) is the go-to rescue inhaler for bronchospasm in asthma and COPD. It works within minutes and is safe when used as needed. Overuse is a warning sign requiring controller therapy (typically inhaled corticosteroids), not just more Asthalin.